Norway Analgesic Industry Outlook 2022 - 2026

See how Norway Analgesic performed compared to key markets such as Germany, Spain and Canada.

Key Market Indicators

Sales of analgesic medicines in Norway are expected to reach $187 million by 2026. In 2021, the market was valued at $180 million. This represents a 0.8% annual growth rate since 2007. Norway was the ninth-largest market for analgesic medicines in 2021, behind Sweden ($180 million). Spain, Canada and Italy ranked second, third and fourth, respectively.

Marketing Banner

Norway Analgesic Market Data and Forecasts

How much will Norway Analgesic Market grow to 2026?

Forecast: Analgesic Medicine Use in Norway
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Norway
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Norway
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Norway
Forecast: Analgesic Medicine Sales in Norway
More in Analgesic Industry for 2028